To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Find out MoreSyncona Share Price | |
---|---|
Price | 128.40 |
Bid | 127.40 |
Ask | 128.80 |
Change | 1.40 (1.10%) |
Volume | 791,286 |
Open | 125.80 |
High | 128.40 |
Low | 125.60 |
Prev. Close | 127.00 |
Currency | GBX |
---|---|
Issue Country | GG |
Shares in Issue | 653.04m |
Market Capitalisation | £838.50m |
Market Size | 10,000 |
52 Week High | 162.20 |
52 Week High Date | 24-May-2023 |
52 Week Low | 105.00 |
52 Week Low Date | 28-Sep-2023 |
# Trades | 110 |
---|---|
Vol. Sold | 361,273 |
Sold Value | £458.83k |
Vol. Bought | 266,674 |
Bought Value | £339.20k |
PE Ratio | -15.3222 |
Earnings | -8.38 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 17:49:54 | 127.879 | 9 | Unknown* | 127.40 | 128.80 | 11.51 | O Ordinary Was reported as OTC |
26-Apr-24 | 17:49:54 | 128.213 | 3 | Unknown* | 127.40 | 128.80 | 3.85 | O Ordinary Was reported as OTC |
26-Apr-24 | 17:38:20 | 126.247 | 34,024 | Unknown* | 127.40 | 128.80 | 42.95k | O Ordinary Was reported as OTC |
26-Apr-24 | 17:22:57 | 128.40 | 470 | Unknown* | 127.40 | 128.80 | 603.48 | O Ordinary Was reported as OTC |
26-Apr-24 | 16:56:46 | 128.406 | 2,890 | Unknown* | 127.40 | 128.80 | 3,711 | O Ordinary Was reported as OTC |
26-Apr-24 | 16:35:14 | 128.40 | 18,794 | Buy* | 127.40 | 128.80 | 24.13k | UT Uncrossing Trade |
26-Apr-24 | 16:23:04 | 127.5753 | 3,150 | Sell* | 127.40 | 128.40 | 4,019 | O Ordinary |
26-Apr-24 | 16:19:22 | 127.8106 | 50 | Sell* | 127.40 | 128.40 | 63.91 | O Ordinary |
26-Apr-24 | 16:18:44 | 127.40 | 1 | Sell* | 127.40 | 128.40 | 1.27 | A Automatic Execution |
26-Apr-24 | 16:18:44 | 127.40 | 1 | Sell* | 127.40 | 128.40 | 1.27 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
09-Mar-22 | 09-Mar-22 | Buy | Robert Hutchinson held the position of Independent Non-Executive Director at the time of this trade.Robert Hutchinson | 171.80 | GBX | 26,000 | 94,827 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 222.12 | GBX | 639,885 | 2,000,000 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 223.88 | GBX | 3,222,943 | 2,000,000 |
12-May-21 | 11-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 202.05 | GBX | 2,137,172 | 2,000,000 |
06-Apr-21 | 01-Apr-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 250.01 | GBX | 317,961 | 2,000,000 |
We are focused on maximising value at all points of the investment cycle to deliver transformational treatments to patients